Pheochromocytoma/paraganglioma syndrome 2

MONDO:0011121

An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the SDHAF2 gene, characterized by an increased risk of paraganglioma, particularly head and neck paragangliomas.

Also known as: SDHAF2 paraganglioma, SDHAF2-related tumor predisposition, paraganglioma caused by mutation in SDHAF2, paragangliomas 2, paragangliomas type 2, pheochromocytoma/paraganglioma syndrome 2, PGL2, SDHAF2-related hereditary paraganglioma-pheochromocytoma syndrome (paragangliomas 2)

2847 clinical trials for this condition and its sub-types, 0 tagged with Pheochromocytoma/paraganglioma syndrome 2 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Malignant endocrine neoplasm (2932) ↑ Central nervous system cancer (1706) ↑ Malignant urinary system neoplasm (1668) ↑ Autosomal dominant disease (699) ↑ Peripheral nervous system cancer (67) ↑ Paraganglioma (57) ↑ Hereditary pheochromocytoma-paraganglioma (6)

Including sub-types (2847) Tagged with Pheochromocytoma/paraganglioma syndrome 2 (0)

We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.